# Multiple Myeloma [MM] vs HemeOncBuddy

Multiple Myeloma [MM] and HemeOncBuddy both sit at 5.0 stars, but that hides the real split: 100% of HemeOncBuddy's written reviews are positive against 50% of Multiple Myeloma [MM]'s. HemeOncBuddy also leads on ratings volume (19 vs 1). Multiple Myeloma [MM]'s advantage is update cadence (every 5 weeks vs every 24 months). On price, rating, ads and in-app purchases there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

On the App Store both sit at effectively the same score — 5.0 for Multiple Myeloma [MM] against 5.0 for HemeOncBuddy. That said, the two scores are not equally well evidenced: HemeOncBuddy has 19 ratings behind it against 1, so its average is the more settled of the two. Written reviews are what separate them: 50% of Multiple Myeloma [MM]'s written reviews are positive against 100% of HemeOncBuddy's.

Multiple Myeloma [MM] ships an update every 5 weeks, HemeOncBuddy every 24 months. The most recent releases landed on November 1, 2026 and November 16, 2026 respectively.

## The numbers

| Metric | Multiple Myeloma [MM] | HemeOncBuddy |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [5.0 (1 ratings)](https://appshunter.io/ios/app/multiple-myeloma-mm/id637863661/reviews) | [5.0 (19 ratings)](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336/reviews) |
| Number of ratings | 1 | **19** |
| Positive reviews | 50.0% of reviews | **100.0% of reviews** |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | **Every 5 weeks** | Every 24 months |
| Monetization | Free | Free |
| Size | 24 MB | 16 MB |
| Requires iOS | **14.0** | 15.0 |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Age rating | 12+ | 17+ |
| Developer | [@Point of Care](https://appshunter.io/developer/916313675) | [Veli Bakalov](https://appshunter.io/developer/1579207338) |

## What reviewers say

### Multiple Myeloma [MM]

[App page](https://appshunter.io/ios/app/multiple-myeloma-mm/id637863661)

This clinical decision support tool provides healthcare professionals with curated, evidence-based medical content for managing Multiple Myeloma. It uses AI-powered natural language queries to deliver quick, confidence-rated answers, aiding in better patient care and outcomes.

**Highlights:** AI-powered natural language queries, Evidence-based medical content, Diagnosis, treatment, and care management topics, Case studies, videos, and interviews, Continuing medical education credit, Patient education resources

**Features:** macOS Compatibility

**In-app purchases:** none


### HemeOncBuddy

[App page](https://appshunter.io/ios/app/hemeoncbuddy/id1579207336)

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

**Highlights:** Practice-changing clinical trial summaries, Hematology and Oncology focus, Simplified trial information, Inclusion and exclusion criteria, Primary endpoints and outcomes, Quick reference tool

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is Multiple Myeloma [MM] free?

Multiple Myeloma [MM] is free to download, with no in-app purchases.

### Is HemeOncBuddy free?

HemeOncBuddy is free to download, with no in-app purchases.

### Which has better reviews, Multiple Myeloma [MM] or HemeOncBuddy?

Multiple Myeloma [MM] and HemeOncBuddy are both rated 5.0 out of 5 on the App Store, from 1 and 19 ratings respectively.

### Do Multiple Myeloma [MM] or HemeOncBuddy have ads?

Neither Multiple Myeloma [MM] nor HemeOncBuddy shows ads.

### Which is updated more often, Multiple Myeloma [MM] or HemeOncBuddy?

Multiple Myeloma [MM] ships an update every 5 weeks, and HemeOncBuddy every 24 months. Most recently, Multiple Myeloma [MM] was updated on November 1, 2026 and HemeOncBuddy on November 16, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*
